Session date: 
02/27/2023 - 7:30am to 8:15am

Speaker(s):
David M. Harmon, Jr., M.D.
Mitchell R. Padkins, M.D.

Learning Objectives:

  • Discuss the importance of post-development validation of the Artificial Intelligence enhanced electrocardiogram (AI-ECG) for cardiac amyloidosis
  • Identify the strengths, weaknesses, and potential biases of this AI-ECG algorithm
  • Review relevant literature regarding major complications associated with right heart catheterization and right ventricular biopsies
  • Identify the rates of major complications of right heart catheterizations and right ventricular biopsies in a contemporary cath lab

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
David M. Harmon, Jr., M.D.
Co-presenter: 
Mitchel R. Padkins, M.D.
Support location: 
Minnesota

Please login or register to take this course.
Support location: 
Minnesota